Back to results
CompletedPhase 2

Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes

NCT00734253

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

The Collaborative Study Group

Chicago, Illinois, United States

View on ClinicalTrials.gov
Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes — TrialFind